Hester Biosciences Ltd Board of Directors
Board of Directors at Hester Biosciences Ltd
Independent Director
Independent Director
Independent Director
Chairman (Non-Executive)
Independent Director
Key Highlights
- Bhupendra V Gandhi continues to serve as the Chairman & Non Executive Dir. in 2026, maintaining the same position as in the previous year.
- Rajiv D Gandhi continues to serve as the ED / MD / CEO / Promoter in 2026, maintaining the same position as in the previous year.
- PRIYA RAJIV GANDHI continues to serve as the Executive Director in 2026, maintaining the same position as in the previous year.
- Sanjiv D Gandhi continues to serve as the Non Executive Director in 2026, maintaining the same position as in the previous year.
- Sandhya Patel joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Hester Biosciences Ltd
NSE: HESTERBIO
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 29 Jul 2026 | 2493.65 |
| 28 Jul 2026 | 2525.1 |
| 27 Jul 2026 | 2528.5 |
| 24 Jul 2026 | 2364.5 |
| 23 Jul 2026 | 2363.55 |
| 22 Jul 2026 | 2429.25 |
| 21 Jul 2026 | 2452.3 |
| 20 Jul 2026 | 2517.55 |
| 17 Jul 2026 | 2445.15 |
| 16 Jul 2026 | 2436.1 |
Company Fundamentals for Hester Biosciences Ltd
Market Cap
2,121 Cr
EPS
63.0
P/E Ratio (TTM)
39.6
P/B Ratio (TTM)
5.9
Day’s High
2549.1
Day’s Low
2456.65
DTE
0.5
ROE
15.4
52 Week High
2661.65
52 Week Low
1250.95
ROCE
14.3
Market Price of Hester Biosciences Ltd
1M
1Y
3Y
5Y
Hester Biosciences Ltd News Hub
Hester Biosciences consolidated net profit rises 8.01% in the June 2024 quarter
Net profit of Hester Biosciences rose 8.01% to Rs 6.34 crore in the quarter ended June 2024 as again
Read more
02 Aug 24
Hester Biosciences announces board meeting date
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 28 October 2024.
Read more
21 Oct 24
Hester Biosciences consolidated net profit rises 100.49% in the September 2024 quarter
Net profit of Hester Biosciences rose 100.49% to Rs 8.20 crore in the quarter ended September 2024 a
Read more
28 Oct 24
Hester Biosciences receives reaffirmation in credit rating for bank facilities
Hester Biosciences has received reaffirmation in credit ratings for bank facilities at CARE BBB+; St
Read more
20 Dec 24
